Crossmark

Community-engaged implementation of a safety bundle for pregnancy-related severe hypertension in the outpatient setting: protocol for a type 3 hybrid study with a multiple baseline design

Crossref DOI link: https://doi.org/10.1186/s12913-024-11579-8

Published Online: 2024-09-30

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Leeman, Jennifer

Rohweder, Catherine L.

Lin, Feng-Chang

Lightfoot, Alexandra F.

Costello, Jennifer Medearis

Farahi, Narges

Harper, Kimberly

Quist-Nelson, Johanna

Teal, E. Nicole

Vu, Maihan B.

Wheeler, Sarahn

Menard, M. Kathryn
Funding

Funding for this research was provided by:

National Heart, Lung, and Blood Institute (OT2HL158287, OT2HL158287, OT2HL158287, OT2HL158287, OT2HL158287, OT2HL158287, OT2HL158287, OT2HL158287, OT2HL158287, OT2HL158287, OT2HL158287, OT2HL158287)
License Information

Text and Data Mining valid from 2024-09-30

Version of Record valid from 2024-09-30
More Information

Article History

Received: 6 June 2024

Accepted: 11 September 2024

First Online: 30 September 2024

Declarations

:

: The AC<sup>3</sup>HIEVE Clinical Trial was approved by the Office of Human Research Ethics at The University of North Carolina at Chapel Hill, IRB#23–0968, on 8/17/23. All study participants will provide informed consent.

: Not applicable.

: The AC<sup>3</sup>HIEVE clinical trial is sponsored by The University of North Carolina at Chapel Hill.

: The authors declare no competing interests.

Document is current

Any future updates will be listed below